Linagliptin & Metformin Hydrochloride '"''''

Linagliptin & Metformin Hydrochloride
LINALIGLIP 2.5/500  
Linagliptin is an oral medication that belongs to a class of drugs known as dipeptidyl peptidase-4 (DPP-4) inhibitors.
It works by inhibiting the enzyme DPP-4, which breaks down incretin hormones. Incretin hormones stimulate the pancreas to release insulin and reduce the liver's production of glucose.
By inhibiting DPP-4, linagliptin increases the levels of these incretin hormones, which in turn helps lower blood sugar levels in people with type 2 diabetes.
Metformin is another oral medication used to treat type 2 diabetes.
It belongs to the biguanide class of drugs and primarily works by reducing the production of glucose in the liver and improving the sensitivity of muscle cells to insulin.
Metformin does not increase insulin production but rather helps the body use insulin more effectively.
Steris Healthcare Pvt. Ltd. is a Leading Pharmaceutical Company in India. Established in the year of May 2018. We have 750+ Products & 16+ Super Specialty Segments. Every week we have a new product in our portfolio. In Last 4 years we are dealing in Chronic Therapy and in 4 years we grow by 200% Annually, because we deal in high quality medicine. Steris medicine manufactures at WHO-GMP Approved Plants & We have Legal manufacturing contracts with all leading manufacturers of India. Today we have 1000+ Business Franchise Partners in PAN India. Steris's medicine supply in India's Top or Reputed Hospitals, Pharmacy, Government use or Railway use. Grow with a similar pace with the STERIS. Be first to launch like us.
For further information please contact:
contact@sterispharma.com
order now:
https://www.sterisonline.com/product/linaliglip-2-5-500-134273